EC Healthcare (HKG:2138)
Hong Kong · Delayed Price · Currency is HKD 0.3750
-0.0050 (-1.32%)
Jul 17, 2026, 3:52 PM HKT
EC Healthcare Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -402.72 | -167.19 | -18.95 | 69.65 | 197.5 |
Depreciation & Amortization | 512.24 | 629.19 | 623.74 | 584.85 | 430.36 |
Other Amortization | - | 1.78 | 1.81 | 1.89 | 2 |
Loss (Gain) From Sale of Assets | - | -266.92 | 1.84 | -3.64 | -19.12 |
Asset Writedown & Restructuring Costs | - | 184.29 | 26.38 | 5.28 | -10.8 |
Loss (Gain) From Sale of Investments | - | 26.75 | 24.58 | 19.09 | 11.57 |
Loss (Gain) on Equity Investments | - | 95.43 | -5.43 | -12.33 | 0.67 |
Stock-Based Compensation | - | 20.27 | 11.95 | 63.12 | 27.69 |
Other Operating Activities | 497.04 | 100.21 | 72.03 | 45.96 | 103.26 |
Change in Accounts Receivable | - | -9.57 | -46.04 | -36.32 | 51.23 |
Change in Inventory | - | -9.92 | -14.31 | 19.97 | -45.19 |
Change in Accounts Payable | - | -11.34 | -11.53 | -14.24 | -0.34 |
Change in Unearned Revenue | - | -37.63 | -56.14 | -59.82 | 91.14 |
Change in Other Net Operating Assets | - | 187.87 | 79.17 | -78.19 | -231.61 |
Operating Cash Flow | 606.56 | 743.24 | 689.1 | 605.28 | 608.36 |
Operating Cash Flow Growth | -18.39% | 7.86% | 13.85% | -0.51% | -2.00% |
Capital Expenditures | - | -57.17 | -161.22 | -411.01 | -260.27 |
Sale of Property, Plant & Equipment | - | 23.22 | 41.29 | 12.38 | 43.56 |
Cash Acquisitions | - | -43.89 | -96.01 | -62.11 | -286.95 |
Divestitures | - | 440.34 | 0.32 | - | - |
Sale (Purchase) of Intangibles | - | - | - | -1.48 | - |
Investment in Securities | - | -24 | -155.62 | -18.02 | -71.9 |
Other Investing Activities | -275.81 | 2.79 | 12.89 | -243.53 | 4.37 |
Investing Cash Flow | -275.81 | 341.28 | -358.36 | -723.77 | -571.19 |
Short-Term Debt Issued | - | - | 10 | - | - |
Long-Term Debt Issued | - | 112.5 | 686.64 | 494.33 | - |
Total Debt Issued | - | 112.5 | 696.64 | 494.33 | - |
Long-Term Debt Repaid | - | -534.43 | -823.13 | -357.12 | -555.04 |
Total Debt Repaid | - | -534.43 | -823.13 | -357.12 | -555.04 |
Net Debt Issued (Repaid) | - | -421.93 | -126.49 | 137.22 | -555.04 |
Issuance of Common Stock | - | - | - | 8.51 | 811.77 |
Common Dividends Paid | - | -11.85 | -55.69 | -118 | -271.96 |
Other Financing Activities | -570.48 | -200 | -304.29 | -67.84 | -84.73 |
Financing Cash Flow | -570.48 | -633.79 | -486.46 | -40.12 | -99.95 |
Foreign Exchange Rate Adjustments | 2.76 | -0.45 | -0.52 | -1.76 | 1.95 |
Net Cash Flow | -236.98 | 450.29 | -156.23 | -160.37 | -60.84 |
Free Cash Flow | 606.56 | 686.07 | 527.88 | 194.27 | 348.09 |
Free Cash Flow Growth | -11.59% | 29.97% | 171.73% | -44.19% | -28.22% |
Free Cash Flow Margin | 16.09% | 16.57% | 12.54% | 5.01% | 11.92% |
Free Cash Flow Per Share | 0.51 | 0.58 | 0.45 | 0.16 | 0.30 |
Cash Interest Paid | - | 78.77 | 91.61 | 31.15 | 24.2 |
Cash Income Tax Paid | - | 72.63 | 49.96 | 85.51 | 67.32 |
Levered Free Cash Flow | 444.96 | 558.4 | 225.53 | 439.94 | 449.14 |
Unlevered Free Cash Flow | 489.76 | 615.09 | 288.55 | 479.72 | 479.71 |
Change in Working Capital | - | 119.41 | -48.85 | -168.6 | -134.77 |